checkAd

     335  0 Kommentare Aequus Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders - Seite 3

    Lesen Sie auch

    Contact Information:

    Aequus Investor Relations
    Email: investors@aequuspharma.ca
    Phone: 604-336-7906

    Diskutieren Sie über die enthaltenen Werte


    Seite 3 von 3

    Verfasst von Marketwired
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Aequus Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders - Seite 3 VANCOUVER, BC--(Marketwired - March 02, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that through a previously announced Research Service Contract with Transdermal Research Pharma …